PERITONEAL NEOPLASMS
Clinical trials for PERITONEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for PERITONEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a breast cancer pill keep ovarian cancer at bay?
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding the drug letrozole to standard maintenance therapy helps prevent ovarian cancer from coming back. It will involve 540 women with ER-positive ovarian, fallopian tube, or peritoneal cancer who have completed initial surgery and che…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing whether adding an experimental drug called relacorilant to standard chemotherapy helps control advanced gynecologic cancers. It will enroll about 270 patients with ovarian, fallopian tube, peritoneal, or endometrial cancer that has returned or spread. The ma…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Major trial launches for new ovarian cancer treatment
Disease control Recruiting nowThis large, two-part study is testing a new drug called sofetabart mipitecan for people with advanced ovarian, fallopian tube, or peritoneal cancer. Part A is for people whose cancer has stopped responding to standard platinum chemotherapy. Part B is for people whose cancer still…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New fluid strategy aims to cut complications in High-Risk cancer surgery
Disease control Recruiting nowThis study is testing whether adding a protein solution called albumin to standard IV fluids during a major cancer surgery leads to fewer complications. The surgery involves removing tumors from the abdomen and bathing the area with heated chemotherapy. Researchers want to see if…
Matched conditions: PERITONEAL NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC